Blocking inflammatory proteins resulting from chemotherapy reduces cancer spread
Having surgery to remove a tumour, followed by chemotherapy to make sure any lingering shreds of cancer are killed, is a gruelling experience. So it’s disheartening if the cancer then spreads and grows anew, aided in part by the very treatment that was intended to shut it down. This can happen in breast cancer patients, but how chemotherapy prompts the spread, or metastasis, was unclear. Researchers have now discovered that one side-effect of the chemotherapy – connective tissue cells creating an inflammatory environment – ultimately supports remaining crumbs of cancer to spread and regrow in the lungs (mouse lung pictured with breast cancer metastases). Adding an agent to the chemotherapy which blocked the activity of proteins (red) involved in recruiting immune cells to cause inflammation led to a large reduction in cancer spreading. This approach could improve the efficacy of chemotherapy for not just breast cancer, but potentially other types as well.
BPoD stands for Biomedical Picture of the Day. Managed by the MRC London Institute of Medical Sciences the website aims to engage everyone, young and old, in the wonders of biomedicine. Images are kindly provided for inclusion on this website through the generosity of scientists across the globe.
BPoD is also available in Catalan at www.bpod.cat with translations by the University of Valencia.